Vivos Inc. (RDGL)
USD 0.1
(-11.97%)
USD 0.1
(-11.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.61 Million USD | -7.61% |
| 2022 | 1.74 Million USD | 6.64% |
| 2021 | 1.63 Million USD | 74.32% |
| 2020 | 937.53 Thousand USD | 2036.94% |
| 2019 | 43.87 Thousand USD | 166.12% |
| 2018 | 16.48 Thousand USD | 5.03% |
| 2017 | 15.69 Thousand USD | -62.62% |
| 2016 | 41.99 Thousand USD | -83.48% |
| 2015 | 254.26 Thousand USD | 180.88% |
| 2014 | 90.52 Thousand USD | -55.25% |
| 2013 | 202.27 Thousand USD | -82.76% |
| 2012 | 1.17 Million USD | 5.06% |
| 2011 | 1.11 Million USD | -57.76% |
| 2010 | 2.64 Million USD | 3.69% |
| 2009 | 2.54 Million USD | -10.54% |
| 2008 | 2.84 Million USD | -19.73% |
| 2007 | 3.55 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.76 Million USD | 28.02% |
| 2024 Q1 | 1.38 Million USD | -14.15% |
| 2023 Q3 | 1.56 Million USD | -12.47% |
| 2023 Q2 | 1.78 Million USD | 22.43% |
| 2023 Q1 | 1.46 Million USD | -16.13% |
| 2023 Q4 | 1.61 Million USD | 2.78% |
| 2023 FY | 1.61 Million USD | -7.61% |
| 2022 Q2 | 1.1 Million USD | -15.27% |
| 2022 FY | 1.74 Million USD | 6.64% |
| 2022 Q3 | 2.04 Million USD | 84.65% |
| 2022 Q1 | 1.3 Million USD | -19.97% |
| 2022 Q4 | 1.74 Million USD | -14.83% |
| 2021 FY | 1.63 Million USD | 74.32% |
| 2021 Q1 | 2.51 Million USD | 168.69% |
| 2021 Q4 | 1.63 Million USD | -20.04% |
| 2021 Q3 | 2.04 Million USD | -8.46% |
| 2021 Q2 | 2.23 Million USD | -11.36% |
| 2020 Q3 | 57.9 Thousand USD | -80.67% |
| 2020 FY | 937.53 Thousand USD | 2036.94% |
| 2020 Q1 | 12.1 Thousand USD | -72.42% |
| 2020 Q2 | 299.55 Thousand USD | 2375.29% |
| 2020 Q4 | 937.53 Thousand USD | 1519.15% |
| 2019 FY | 43.87 Thousand USD | 166.12% |
| 2019 Q4 | 43.87 Thousand USD | -77.74% |
| 2019 Q3 | 197.05 Thousand USD | 308.1% |
| 2019 Q2 | 48.28 Thousand USD | -15.76% |
| 2019 Q1 | 57.31 Thousand USD | 247.68% |
| 2018 Q3 | 11.73 Thousand USD | 43.74% |
| 2018 Q2 | 8161.00 USD | 1091.39% |
| 2018 Q1 | 685.00 USD | -95.64% |
| 2018 FY | 16.48 Thousand USD | 5.03% |
| 2018 Q4 | 16.48 Thousand USD | 40.53% |
| 2017 Q1 | 25.07 Thousand USD | -40.29% |
| 2017 FY | 15.69 Thousand USD | -62.62% |
| 2017 Q4 | 15.69 Thousand USD | -46.87% |
| 2017 Q3 | 29.54 Thousand USD | -92.16% |
| 2017 Q2 | 376.94 Thousand USD | 1403.13% |
| 2016 Q2 | 77.22 Thousand USD | -75.64% |
| 2016 Q3 | 77.27 Thousand USD | 0.06% |
| 2016 FY | 41.99 Thousand USD | -83.48% |
| 2016 Q1 | 317.02 Thousand USD | 24.68% |
| 2016 Q4 | 41.99 Thousand USD | -45.65% |
| 2015 Q2 | 103.35 Thousand USD | 29.87% |
| 2015 FY | 254.26 Thousand USD | 180.88% |
| 2015 Q4 | 254.26 Thousand USD | 204.75% |
| 2015 Q3 | 83.43 Thousand USD | -19.28% |
| 2015 Q1 | 79.58 Thousand USD | -12.08% |
| 2014 FY | 90.52 Thousand USD | -55.25% |
| 2014 Q1 | 305.42 Thousand USD | 50.99% |
| 2014 Q4 | 90.52 Thousand USD | -41.42% |
| 2014 Q3 | 154.53 Thousand USD | -50.1% |
| 2014 Q2 | 309.66 Thousand USD | 1.39% |
| 2013 Q1 | 759.27 Thousand USD | -35.28% |
| 2013 Q2 | 461.89 Thousand USD | -39.17% |
| 2013 Q3 | 521.73 Thousand USD | 12.96% |
| 2013 Q4 | 202.27 Thousand USD | -61.23% |
| 2013 FY | 202.27 Thousand USD | -82.76% |
| 2012 Q2 | 886.76 Thousand USD | -8.51% |
| 2012 FY | 1.17 Million USD | 5.06% |
| 2012 Q4 | 1.17 Million USD | 43.18% |
| 2012 Q3 | 819.32 Thousand USD | -7.61% |
| 2012 Q1 | 969.23 Thousand USD | -13.2% |
| 2011 Q3 | 1.21 Million USD | -17.18% |
| 2011 Q2 | 1.47 Million USD | -15.84% |
| 2011 FY | 1.11 Million USD | -57.76% |
| 2011 Q4 | 1.11 Million USD | -8.4% |
| 2011 Q1 | 1.74 Million USD | -33.84% |
| 2010 FY | 2.64 Million USD | 3.69% |
| 2010 Q4 | 2.64 Million USD | 1.48% |
| 2010 Q3 | 2.6 Million USD | 12.34% |
| 2010 Q2 | 2.31 Million USD | -3.71% |
| 2010 Q1 | 2.4 Million USD | -5.54% |
| 2009 Q1 | 2.76 Million USD | -2.98% |
| 2009 Q4 | 2.54 Million USD | -5.49% |
| 2009 Q3 | 2.69 Million USD | -0.16% |
| 2009 Q2 | 2.7 Million USD | -2.29% |
| 2009 FY | 2.54 Million USD | -10.54% |
| 2008 FY | 2.84 Million USD | -19.73% |
| 2008 Q4 | 2.84 Million USD | 0.0% |
| 2007 FY | 3.55 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | 7.878% |
| BioElectronics Corporation | 144.38 Thousand USD | -1015.137% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 999 Thousand USD | -61.174% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -84.908% |
| Polarean Imaging plc | 10.86 Million USD | 85.184% |
| AVITA Medical, Inc. | 144.33 Million USD | 98.884% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -409.533% |
| Össur hf. | 1.39 Billion USD | 99.884% |
| Zecotek Photonics Inc. | 2.57 Million USD | 37.42% |
| QHSLab, Inc. | 1.68 Million USD | 4.241% |
| Wellstar International, Inc. | 957.89 Thousand USD | -68.09% |
| Össur hf. | 1.39 Billion USD | 99.884% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 98.436% |
| Escalon Medical Corp. | 4.75 Million USD | 66.159% |
| Aurora Spine Corporation | 11.92 Million USD | 86.497% |
| BrainsWay Ltd. | 62.97 Million USD | 97.443% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | 43.565% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 98.538% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.959% |
| Kelyniam Global, Inc. | 1.63 Million USD | 1.382% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -33.475% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -2840.973% |
| Nanomix Corporation | 982.05 Thousand USD | -63.955% |
| Theraclion SA | 18.66 Million EUR | 91.373% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -783.809% |
| Positron Corporation | 1.76 Million USD | 8.912% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -115.147% |
| Lombard Medical, Inc. | 67.76 Million USD | 97.624% |
| ALR Technologies Inc. | 193.21 Thousand USD | -733.324% |
| Stratec SE | 529.71 Million USD | 99.696% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -62.262% |
| Heart Tronics, Inc. | 4.04 Million USD | 60.233% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 27.211% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 92.162% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 92.817% |
| VMS Rehab Systems, Inc. | 4.45 USD | -36182461.798% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 3.528% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -118.251% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -253.258% |
| United American Healthcare Corporation | 10.37 Million USD | 84.487% |
| ECGI Holdings, Inc. | 5.2 Million USD | 69.044% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -4664.526% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 24.716% |
| Urologix, Inc. | 5.66 Million USD | 71.588% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 28.584% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 92.088% |
| SS Innovations International, Inc. | 25.47 Million USD | 93.681% |
| Qualis Innovations, Inc. | 2431.00 USD | -66132.991% |
| Smith & Nephew plc | 9.97 Billion USD | 99.984% |
| NIOX Group Plc | 116.47 Million USD | 98.618% |
| Fuse Medical, Inc. | 16.25 Million USD | 90.097% |
| Broncus Holding Corporation | 195.75 Million USD | 99.177% |
| Brain Scientific Inc. | 11.74 Million USD | 86.289% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -53.392% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -5503.355% |